Keyphrases
Type 2 Diabetic Patients
100%
Glycemic Control
100%
Systematic Meta-analysis
100%
Bile Acid Sequestrants
100%
Meta-analysis of Randomized Controlled Trials
100%
Type 2 Diabetes Mellitus (T2DM)
33%
Placebo
33%
Subgroup Analysis
16%
Colesevelam
16%
Adverse Events
16%
Diabetes Management
16%
Statins
16%
Mean Group
16%
Sitagliptin
16%
Low Hemoglobin
16%
Sensitivity Analysis
16%
Risk of Bias
16%
End of Treatment
16%
Random-effects Meta-analysis
16%
Confidence Interval
16%
Low Risk
16%
Clinically Significant
16%
Control Algorithm
16%
Active Comparator
16%
Safety Data
16%
Hemoglobin A1c (HbA1c)
16%
Bias Control
16%
Publication Bias
16%
Medicine and Dentistry
Randomized Controlled Trial
100%
Patient with Type 2 Diabetes
100%
Glycemic Control
100%
Bile Acid Sequestrant
100%
Systematic Review with Meta-Analysis
100%
Maturity Onset Diabetes of the Young
33%
Placebo
33%
Meta-Analysis
16%
Hemoglobin A1c
16%
Adverse Event
16%
Colesevelam
16%
Subgroup Analysis
16%
Diabetes
16%
Sitagliptin
16%
Statin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Bile Acid Sequestrant
100%
Non Insulin Dependent Diabetes Mellitus
100%
Placebo
33%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Colesevelam
16%
Hemoglobin A1c
16%
Adverse Event
16%
Sitagliptin
16%
Neuroscience
Meta-Analysis
100%
Bile Acid Sequestrant
100%
Randomized Controlled Trial
100%
Placebo
33%
Statin
16%
Hemoglobin A1c
16%
Colesevelam
16%
Sitagliptin
16%
Psychology
Systematic Review
100%
Meta-Analysis
100%
Publication Bias
33%
Immunology and Microbiology
Glycemic Control
100%
Glycosylated Hemoglobin
33%